CD4 and demyelinating disease: Our results demonstrate that preexisting naive VP2-specific CD4+ T cells promote the pathogenesis of TMEV-induced demyelinating disease at high initial viral loads, but VP2-primed VP2-specific CD4+ T cells protect against the pathogenesis.